Global Specialty Fats and Oils Market Report 2021: Market to Reach $19.1 Billion by 2027 - U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 10% CAGR - ResearchAndMarkets.com
Global Specialty Fats and Oils Market to Reach $19.1 Billion by 2027
Amid the COVID-19 crisis, the global market for Specialty Fats and Oils estimated at US$12.2 Billion in the year 2020, is projected to reach a revised size of US$19.1 Billion by 2027, growing at a CAGR of 6.6% over the period 2020-2027.
Specialty Oils, one of the segments analyzed in the report, is projected to record 6.4% CAGR and reach US$11.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Specialty Fats segment is readjusted to a revised 6.9% CAGR for the next 7-year period.
The U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 10% CAGR
The Specialty Fats and Oils market in the U.S. is estimated at US$3.3 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$4.1 Billion by the year 2027 trailing a CAGR of 9.9% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.6% and 5.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...